Regeneron Pharmaceuticals (NASDAQ:REGN) traded lower in the premarket Thursday despite a newly announced $3B worth of share buybacks as the Eylea maker fell short of Street forecasts with its Q1 2024 ...
Source LinkRegeneron Pharmaceuticals (NASDAQ:REGN) traded lower in the premarket Thursday despite a newly announced $3B worth of share buybacks as the Eylea maker fell short of Street forecasts with its Q1 2024 ...
Source Link
Comments